[go: up one dir, main page]

MX2015008011A - Suplementos y sistemas de monitoreo para la dosificacion de los suplementos. - Google Patents

Suplementos y sistemas de monitoreo para la dosificacion de los suplementos.

Info

Publication number
MX2015008011A
MX2015008011A MX2015008011A MX2015008011A MX2015008011A MX 2015008011 A MX2015008011 A MX 2015008011A MX 2015008011 A MX2015008011 A MX 2015008011A MX 2015008011 A MX2015008011 A MX 2015008011A MX 2015008011 A MX2015008011 A MX 2015008011A
Authority
MX
Mexico
Prior art keywords
supplements
state
dosing
monitoring systems
monitoring
Prior art date
Application number
MX2015008011A
Other languages
English (en)
Inventor
Joel R L Ehrenkranz
Original Assignee
Joel R L Ehrenkranz
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Joel R L Ehrenkranz filed Critical Joel R L Ehrenkranz
Publication of MX2015008011A publication Critical patent/MX2015008011A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue
    • A61B5/1455—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue using optical sensors, e.g. spectral photometrical oximeters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/68—Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient
    • A61B5/6887—Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient mounted on external non-worn devices, e.g. non-medical devices
    • A61B5/6898—Portable consumer electronic devices, e.g. music players, telephones, tablet computers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/12—Ketones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A61K31/522—Purines, e.g. adenine having oxo groups directly attached to the heterocyclic ring, e.g. hypoxanthine, guanine, acyclovir
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/18—Iodine; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/26—Iron; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/56—Materials from animals other than mammals
    • A61K35/60—Fish, e.g. seahorses; Fish eggs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/889—Arecaceae, Palmae or Palmaceae (Palm family), e.g. date or coconut palm or palmetto
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/906—Zingiberaceae (Ginger family)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N5/00—Radiation therapy
    • A61N5/06—Radiation therapy using light
    • A61N5/0613—Apparatus adapted for a specific treatment
    • A61N5/062—Photodynamic therapy, i.e. excitation of an agent
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
    • G01N21/17—Systems in which incident light is modified in accordance with the properties of the material investigated
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
    • G01N21/84—Systems specially adapted for particular applications
    • G01N21/8483—Investigating reagent band
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/483—Physical analysis of biological material
    • G01N33/487—Physical analysis of biological material of liquid biological material
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/483—Physical analysis of biological material
    • G01N33/487—Physical analysis of biological material of liquid biological material
    • G01N33/49—Blood
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/52—Use of compounds or compositions for colorimetric, spectrophotometric or fluorometric investigation, e.g. use of reagent paper and including single- and multilayer analytical elements
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54366—Apparatus specially adapted for solid-phase testing
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54366—Apparatus specially adapted for solid-phase testing
    • G01N33/54386—Analytical elements
    • G01N33/54387—Immunochromatographic test strips
    • G01N33/54388—Immunochromatographic test strips based on lateral flow
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B2560/00—Constructional details of operational features of apparatus; Accessories for medical measuring apparatus
    • A61B2560/04—Constructional details of apparatus
    • A61B2560/0443—Modular apparatus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/145—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue
    • A61B5/14507—Measuring characteristics of blood in vivo, e.g. gas concentration or pH-value ; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid or cerebral tissue specially adapted for measuring characteristics of body fluids other than blood
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N21/00—Investigating or analysing materials by the use of optical means, i.e. using sub-millimetre waves, infrared, visible or ultraviolet light
    • G01N21/17—Systems in which incident light is modified in accordance with the properties of the material investigated
    • G01N2021/1765—Method using an image detector and processing of image signal
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H20/00—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance
    • G16H20/30—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to physical therapies or activities, e.g. physiotherapy, acupressure or exercising
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16H—HEALTHCARE INFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR THE HANDLING OR PROCESSING OF MEDICAL OR HEALTHCARE DATA
    • G16H20/00—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance
    • G16H20/60—ICT specially adapted for therapies or health-improving plans, e.g. for handling prescriptions, for steering therapy or for monitoring patient compliance relating to nutrition control, e.g. diets
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A90/00—Technologies having an indirect contribution to adaptation to climate change
    • Y02A90/10—Information and communication technologies [ICT] supporting adaptation to climate change, e.g. for weather forecasting or climate simulation

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Physics & Mathematics (AREA)
  • Hematology (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Pathology (AREA)
  • Urology & Nephrology (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Food Science & Technology (AREA)
  • Microbiology (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Cell Biology (AREA)
  • Biophysics (AREA)
  • Medical Informatics (AREA)
  • Inorganic Chemistry (AREA)
  • Surgery (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Mycology (AREA)
  • Botany (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Optics & Photonics (AREA)
  • Multimedia (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • Ecology (AREA)
  • Radiology & Medical Imaging (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)

Abstract

Métodos para monitorear y ajustar un estado psicológico de un sujeto. Los métodos incluyen (1) proporcionar un sujeto con uno o más parámetros fisiológicos definidos por uno o más biométricos, (2) monitorear un analito biométrico seleccionado asociado con un biométrico seleccionado para definir un estado del biométrico seleccionado, (3) con base en los resultados del monitoreo, ajustar el estado del biométrico seleccionado por medio de la administración a sujeto de un suplemento seleccionado para afectar el estado del biométrico seleccionado.
MX2015008011A 2012-12-21 2013-12-20 Suplementos y sistemas de monitoreo para la dosificacion de los suplementos. MX2015008011A (es)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US201261740979P 2012-12-21 2012-12-21
US201261745240P 2012-12-21 2012-12-21
US201361910749P 2013-12-02 2013-12-02
PCT/US2013/077217 WO2014100715A2 (en) 2012-12-21 2013-12-20 Supplements and monitoring systems for dosing of the supplements

Publications (1)

Publication Number Publication Date
MX2015008011A true MX2015008011A (es) 2016-02-25

Family

ID=50979410

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2015008011A MX2015008011A (es) 2012-12-21 2013-12-20 Suplementos y sistemas de monitoreo para la dosificacion de los suplementos.

Country Status (5)

Country Link
US (1) US10352920B2 (es)
EP (1) EP2934558A4 (es)
CA (1) CA2896082A1 (es)
MX (1) MX2015008011A (es)
WO (1) WO2014100715A2 (es)

Families Citing this family (45)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9787815B2 (en) * 2013-01-21 2017-10-10 Cornell University Smartphone-based apparatus and method
EP3089656A4 (en) * 2014-01-03 2017-09-06 Mc10, Inc. Integrated devices for low power quantitative measurements
CN104749385A (zh) * 2015-02-06 2015-07-01 普迈德（北京）科技有限公司 定量检测25-羟基维生素d的免疫层析试剂条及其制备方法
CA2995732A1 (en) * 2015-09-16 2017-03-23 Thermo Electron Scientific Instruments Llc Image analysis system and method
JP6045738B1 (ja) * 2016-03-08 2016-12-14 株式会社リクルートホールディングス 精子簡易検査キット、システム及び精子の簡易検査を行う方法
FR3048778A1 (fr) * 2016-03-10 2017-09-15 Archimej Tech Dispositif d'analyse, de preference pour chimiometrie d'un echantillon sanguin.
US10324022B2 (en) 2016-05-11 2019-06-18 Bonraybio Co., Ltd. Analysis accuracy improvement in automated testing apparatus
US9958658B2 (en) 2016-05-11 2018-05-01 Bonraybio Co., Ltd. Testing equipment with magnifying function
US10852290B2 (en) 2016-05-11 2020-12-01 Bonraybio Co., Ltd. Analysis accuracy improvement in automated testing apparatus
US9959621B2 (en) 2016-05-11 2018-05-01 Bonraybio Co., Ltd. Testing apparatus with dual cameras
US9958665B2 (en) 2016-05-11 2018-05-01 Bonraybio Co., Ltd. Testing equipment with magnifying function
US10281386B2 (en) 2016-05-11 2019-05-07 Bonraybio Co., Ltd. Automated testing apparatus
EP3469359B1 (en) * 2016-06-14 2020-07-22 Baze Labs AG Personalised nutrient dosing with on-going feedback loop
EP3472654A1 (en) * 2016-06-20 2019-04-24 Ran Biotechnologies, Inc. Viewer device
CA3031979A1 (en) * 2016-08-01 2018-02-08 IC-MedTech Corp. Ascorbic acid, quinone compound, and sodium glucose cotransporter inhibitor for treating cancer
CN106770819B (zh) * 2016-12-05 2019-07-23 山东省药学科学院 一种液质联用定量检测大鼠血浆中叶酸浓度的方法
WO2018128749A1 (en) * 2017-01-06 2018-07-12 Dnt Scientific Research, Llc Rapid diagnostic test device by driven flow technology
US12282029B2 (en) 2017-05-08 2025-04-22 MPB Fertility, Inc. Portable diagnostic system for ovulation cycle monitoring
US11029321B2 (en) 2017-02-17 2021-06-08 MFB Fertility, Inc. Method of evaluating corpus luteum function by recurrently evaluating progesterone non-serum bodily fluids on multiple days
US11131665B1 (en) 2018-08-22 2021-09-28 MFB Fertility, Inc. Method for evaluating urine of a subject to estimate the fertile window
US11061026B2 (en) 2017-02-17 2021-07-13 MFB Fertility, Inc. System of evaluating corpus luteum function by recurrently evaluating progesterone non-serum bodily fluids on multiple days
US10455072B2 (en) * 2017-03-20 2019-10-22 Labstyle Innovation Ltd. Systems and methods for enabling optical transmission of data between a sensor and a smart device
CN107144568B (zh) * 2017-06-23 2023-06-20 深圳乐普智能医疗器械有限公司 精子分析装置及其分析方法
JP2020525801A (ja) * 2017-06-23 2020-08-27 ボヤント ダイアグノスティックス インコーポレイテッドＶｏｙａｎｔ Ｄｉａｇｎｏｓｔｉｃｓ，Ｉｎｃ． 医療診断システムおよび方法
EP3672733A4 (en) 2017-08-25 2021-03-31 Bio-Rad Laboratories, Inc. SIDE DRAIN PUMP HOUSING
US10098922B1 (en) * 2017-11-30 2018-10-16 Optigenex, Inc. Increasing telomere length in a cell
EP3724642A1 (en) * 2017-12-13 2020-10-21 Bloom Diagnostics AG Preparation device, diagnostic apparatus, diagnostic kit and diagnostic system
CN108849445B (zh) * 2018-03-20 2020-11-06 江西天元药业有限公司 一种花生芽中的白藜芦醇的条件培育系统及方法
KR102577993B1 (ko) * 2018-04-06 2023-09-18 프리시젼바이오 주식회사 유체 검사 카트리지, 이를 포함하는 유체 검사장치 및 검사장치의 제어방법
JP7417537B2 (ja) * 2018-05-07 2024-01-18 イムンディアグノスティック アー ゲー 定量的なラテラルフロークロマトグラフィーの分析システム
EP3611494A1 (en) 2018-08-17 2020-02-19 Koninklijke Philips N.V. System and method for providing an indication of a person's gum health
US12181465B2 (en) 2018-08-22 2024-12-31 MFB Fertility, Inc. Method for evaluating urine of a subject to estimate the fertile window by evaluating for the presence of analytes of estrogen and progesterone
US20200209162A1 (en) * 2018-12-31 2020-07-02 Marco De Angeli Smart label architecture with organic leds
CN109975461B (zh) * 2019-04-10 2022-03-22 中生北控生物科技股份有限公司 维生素d及其代谢物的质谱检测用校准品和质控品及其制备方法和应用
CN112010933B (zh) * 2019-05-30 2022-08-02 首都医科大学 姜黄素-4-O-乙酰-Arg-Gly-Asp-Phe锶盐，其合成,活性和应用
EP4164754A4 (en) * 2020-06-11 2023-08-16 Siemens Healthcare Diagnostics, Inc. ANTI-COUNTERFEITING FOR TEST STRIPS
US20220020481A1 (en) 2020-07-20 2022-01-20 Abbott Laboratories Digital pass verification systems and methods
US20220065847A1 (en) * 2020-08-28 2022-03-03 Izhar Hasan Safe handling later.al flow immunoassay cassettes for point of care testing
US11139064B1 (en) * 2020-12-29 2021-10-05 Kpn Innovations, Llc. Systems and methods for generating a body degradation reduction program
US12087428B2 (en) * 2020-12-29 2024-09-10 Kpn Innovations Llc Systems and methods for generating a body degradation reduction program
WO2022223421A1 (en) * 2021-04-19 2022-10-27 Dsm Ip Assets B.V. Use of mg2+, vitamin c and coenzyme q10 in lactate threshold training
GB2606734B (en) * 2021-05-18 2023-10-04 Dx Tek Ltd Diagnostic testing
US20240412829A1 (en) * 2021-07-22 2024-12-12 Assaya Llc Medical test hub with display
GB202318013D0 (en) * 2023-11-24 2024-01-10 Biovit Ltd Optimising personalised nutrition product based on rate of uptake for individual micronutrients
WO2025226996A1 (en) * 2024-04-24 2025-10-30 4Life Patents, Llc Immune health evaluation

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4888414A (en) * 1987-04-09 1989-12-19 Board Of Regents, University Of Texas System Insulin-binding peptides and uses thereof
US5200345A (en) * 1989-08-16 1993-04-06 New York University Methods and apparatus for quantifying tissue damage, determining tissue type, monitoring neural activity, and determining hematocrit
US6521247B1 (en) * 1999-08-13 2003-02-18 Warner Chilcott Laboratories Ireland Limited Dual iron containing nutritional supplement
IN188857B (es) * 2000-07-14 2002-11-16 Govind Kane Dr Shantaram
US7371582B2 (en) * 2002-01-23 2008-05-13 Boditechmed Inc. Lateral flow quantitative assay method and strip and laser-induced fluorescence detection device therefor
WO2005015217A1 (ja) * 2003-08-11 2005-02-17 Kyowa Medex Co., Ltd. 測定対象物測定器具、測定装置および測定方法
EP1676862B1 (en) * 2003-09-24 2010-12-22 Kyowa Hakko Kirin Co., Ltd. Recombinant antibody against human insulin-like growth factor
JP2008509224A (ja) * 2004-08-09 2008-03-27 クレアグリ， インコーポレイテッド 炎症状態を治療するためのオリーブ組成物及び方法
PL3026874T3 (pl) * 2005-04-01 2020-05-18 Polymer Technology Systems, Inc. Składnik do badania płynu ustrojowego do detekcji analitu
US20110202033A1 (en) 2006-07-11 2011-08-18 Noah Weisleder Compositions and methods for the treatment and prevention of cardiac ischemic injury
EP2660596B1 (en) * 2008-10-02 2018-06-13 Gaia Medical Institute Health test for a broad spectrum of health problems
US9494570B2 (en) * 2008-10-02 2016-11-15 Pixcell Medical Technologies Ltd. Optical imaging based on viscoelastic focusing
US20110015154A1 (en) 2009-07-20 2011-01-20 Kellermann Gottfried H Supporting acetylcholine function
US20130134293A1 (en) * 2010-03-02 2013-05-30 Koninklijke Philips Electronics N.V. Optical examinations with controlled input light
JP5804395B2 (ja) 2011-02-03 2015-11-04 ポップ テスト オンコロジー エルエルシー 診断と治療のためのシステムおよび方法
US8889424B2 (en) * 2011-09-13 2014-11-18 Joel R. L. Ehrenkranz Device and method for performing a diagnostic test
EP2786149A2 (en) * 2011-11-29 2014-10-08 Rijksuniversiteit Groningen Methods and kits for determining protein-bound biomarkers
CA2870635C (en) * 2012-04-17 2019-04-09 Joel R. L. Ehrenkranz Device for performing a diagnostic test and methods for use thereof
CA2870648C (en) * 2012-04-17 2018-06-19 Joel R. L. Ehrenkranz Device for performing an enzyme-based diagnostic test and methods for use thereof

Also Published As

Publication number Publication date
EP2934558A2 (en) 2015-10-28
WO2014100715A3 (en) 2014-09-04
EP2934558A4 (en) 2016-07-27
WO2014100715A2 (en) 2014-06-26
CA2896082A1 (en) 2014-06-26
US20150338387A1 (en) 2015-11-26
US10352920B2 (en) 2019-07-16

Similar Documents

Publication Publication Date Title
MX2015008011A (es) Suplementos y sistemas de monitoreo para la dosificacion de los suplementos.
PH12016500840A1 (en) Methods of using interleukin-10 for treating diseases and disorders
HK1205964A1 (en) Kit and devices for organ perfusion
EP2972379A4 (en) System and method to manage diabetes based on glucose median, glucose variability, and hypoglycemic risk
WO2013152090A3 (en) Transcutaneous analyte sensors, applicators therefor, and associated methods
WO2014120619A3 (en) Compositions and methods of use in treating metabolic disorders
WO2015081085A3 (en) Methods of treating a tauopathy
MX2014002159A (es) Combinacion farmaceutica para uso en el control glucemico en pacientes con diabetes de tipo 2.
WO2014149781A8 (en) Cloud-based physiological monitoring system
MX2020001369A (es) Sistema de analisis para el cuidado de un paciente.
EP3540069A3 (en) Biosynthetic pathways and products
WO2015023681A3 (en) Swallowing assessment and improvement systems and methods
WO2014152754A3 (en) Methods of diagnosis, selection, and treatment of diseases and conditions caused by or associated with methanogens
WO2014018785A3 (en) Biorefinery control system, components therefor, and methods of use
WO2014106825A3 (en) Methods and devices for identifying improper medical reporting
PH12017500017A1 (en) A combination of vitamin d and zinc and its use
BR112013011259A2 (pt) condições de tratamento associadas com nível aumentado de eotaxina com 25-hidroxivitamina d3
EP3013219A4 (en) Low glucose treatment for people with diabetes
WO2013155528A3 (en) Methods for reducing brain inflammation, increasing insulin sensitivity, and reducing ceramide levels
PH12014502071A1 (en) Beta-hydroxy-beta-methylbutyric acid for imrpoving glucose tolerance
WO2013169956A3 (en) Compositions and methods for modulating mitochondrial pyruvate carrier activity
WO2014159926A3 (en) Medical treatment management
PH12017500084A1 (en) Vitamin b2 and its use
WO2014115033A3 (en) A natriuretic peptide, a diuretic peptide or a vaso dilatory peptide for use in methods of treating cardiovascular indications
PH12016500950A1 (en) Infant nutrition for improvement in insulin sensitivity later in life